The New Zealand Drug Foundation welcomes the introduction of the Psychoactive Substances Bill.

“The bill is a comprehensive and thoughtful response to what is proving to be one of the biggest challenges to drug policy makers around the world,” the foundation executive director, Ross Bell, said today.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.